Bristol-Myers Squibb Company (BMY) (JOBS) to Spin Off Mead Johnson Nutrition Company Stock
11/16/2009
More...
|
Abbott Laboratories (ABT) (JOBS) to Acquire Novel Investigational Biologic from PanGenetics B.V.'s to Treat Chronic Pain for $190 Million
11/12/2009
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) (JOBS), Sanofi-Aventis (France) (SASY.PA) (JOBS), Expand Drug Partnership; Sanofi to Increase Funding to Regeneron to $160 Million
11/11/2009
More...
|
Biovitrum AB and Swedish Orphan AB Combine to Form Swedish Orphan Biovitrum
11/5/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) and Schering-Plough Corporation (SGP) (JOBS) to Complete Merger Today; New Merck Will Begin Combined Operations Tomorrow
11/3/2009
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) (JOBS) Strikes $1 Billion Deal with Takeda Pharmaceutical Co. Ltd. (TKDG.DE) (JOBS) to Co-Develop Weight Loss Drugs
11/2/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) Buys Wellstat Therapeutics Corporation's Type II Diabetes Drug PN2034 For Up To $350 Million
10/21/2009
More...
|
OXiGENE (OXGN) (JOBS) to Buy VaxGen, Inc. (VXGN) for About $22 Million in Stock
10/15/2009
More...
|
GlaxoSmithKline (GSK) in $680 Million RNA Deal with ProSensa B.V.
10/14/2009
More...
|
Onyx Pharmaceuticals, Inc. (ONXX) (JOBS) to Acquire Private Biotech, Proteolix, Inc. (JOBS) for $851 Million
10/13/2009
More...
|
Novartis Pharma AG (NVS) (JOBS) Acquires Exclusive Rights From Vanda Pharmaceuticals, Inc. (VNDA) for Commercialization of Fanapt in the United States and Canada; Novartis to Pay $200 Million Upfront
10/13/2009
More...
|
Heptares Inks $200 Million Tech Pact with Novartis Corporation (NVS) (JOBS)
10/12/2009
More...
|
GlaxoSmithKline (GSK) (JOBS) Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM)
10/7/2009
More...
|
Nektar Therapeutics (NKTR) (JOBS) Signs Licensing Deal with AstraZeneca PLC (AZN) (JOBS) for $1.5 Billion
9/22/2009
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) (JOBS) Launches Hostile Bid for Facet Biotech
9/21/2009
More...
|
Wyeth (WYE) (JOBS) and Ambrx, Inc. (JOBS) Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances
9/18/2009
More...
|
Johnson & Johnson (JNJ) and Elan Corporation PLC (ELN) Announce Closing of Transaction Related to Alzheimer’s Immunotherapy Program and Equity Investment
9/17/2009
More...
|
Bristol-Myers Squibb Company (BMY) (JOBS) Sells Asia Rights to Japan's Taisho Pharmaceutical for $310 Million
9/16/2009
More...
|
Biotech Neurosearch A/S (DK:NEUR) Teams with Johnson & Johnson (JNJ) Unit for Research
8/17/2009
More...
|
Clinical Data, CombinatoRx, Incorporated (CRXX) Strike Deal; Potential $252 Million in Milestones
8/14/2009
More...
|
Forest Laboratories, Inc. (FRX) and AstraZeneca PLC (AZN) to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective
8/12/2009
More...
|
Forest Laboratories, Inc. (FRX) (JOBS) to Sell Nycomed's Lung Drug Daxas in U.S.; Forest to Pay $100 Million Upfront, Up to $500 Million More Later
8/10/2009
More...
|
GlaxoSmithKline (GSK) (JOBS), Vernalis PLC (VNLS) Sign up to $200 Million Cancer Deal
8/7/2009
More...
|
Elan Corporation PLC (ELN) Sues as Biogen, Inc. (JOBS) Seeks Control Over Tysabri
8/7/2009
More...
|
Japan's Hisamitsu Pharmaceutical to Buy Noven Pharmaceuticals Inc. (NOVN) for $430 Million, To Expand U.S. Presence
7/14/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) and Portola Pharmaceuticals, Inc. Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease; Portola to Receive $50M Initially and up to $420M in Payments
7/9/2009
More...
|
Johnson & Johnson (JNJ) to Buy $1 Billion Elan Corporation PLC (ELN) Stake, Work on Alzheimer's
7/6/2009
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Gains Rights to Acorda Therapeutics (ACOR)'s MS Drug; Acorda to Get $110 Million Up Front
7/1/2009
More...
|
Wyeth (WYE), Catalyst Biosciences, Inc. Sign Deal Worth Potentially $500 Million
6/30/2009
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) to Buy Cell Genesys, Inc. (CEGE) for $38 Million
6/30/2009
More...
|
GlaxoSmithKline (GSK) Signs Potential $1 Billion Drug Deal with Chroma Therapeutics
6/24/2009
More...
|
GlaxoSmithKline (GSK) Scraps Synta Pharmaceuticals Deal After Drug Disappoints
6/16/2009
More...
|
Adimab, Inc. Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck & Co., Inc. (MRK) and Roche (RHHBY)
6/16/2009
More...
|
Bayhill Therapeutics, Inc. Enters Exclusive, Worldwide Collaboration with Genentech, Inc. (DNA) (JOBS) for BHT-3021 in Type 1 Diabetes; Deal Could Potentially Exceed $350M
6/10/2009
More...
|
GlaxoSmithKline (GSK) Signs Potential $1 Billion Deuterium Drug Deal with Concert Pharmaceuticals, Inc.
6/3/2009
More...
|
AstraZeneca PLC (AZN) and Merck & Co., Inc. (MRK) (JOBS) Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen
6/1/2009
More...
|
Elixir Pharmaceuticals Signs Option Agreement with a Major Pharmaceutical Company, Novartis Corporation (NVS); Deal Could Exceed $500 Million, Completes $12M Equity Financing
5/20/2009
More...
|
Novartis AG (JOBS) Assumes Rights to Schering-Plough Corporation (SGP) (JOBS) Respiratory Drug
5/19/2009
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) to Acquire IDM Pharma, Inc. (IDMI) for $75 Million, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
5/18/2009
More...
|
Oxford BioTherapeutics and GlaxoSmithKline (GSK) Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies; OBT Eligible for Total of $370 Million
5/18/2009
More...
|
GlobeImmune, Inc. and Celgene Corporation (CELG) Announce $500M Strategic Global Oncology Alliance; GlobeImmune Will Receive $40 Million Upfront
5/15/2009
More...
|
Roche (RHHBY) Partners With Tekmira Pharmaceuticals Corporation to Advance RNAi Product Candidates in $50 Million Deal
5/11/2009
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) in Pact with Biovail Corporation (BVF) for Parkinson's Drug; Acadia Entitled to Receive up to $395 Million
5/4/2009
More...
|
GlaxoSmithKline (GSK) to Buy Stiefel Laboratories for Up to $3.6 Billion
4/20/2009
More...
|
GlaxoSmithKline (GSK) and Pfizer Inc. (PFE) Innovative Agreement Creates Specialist HIV Company
4/16/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) Buys U.S. Cancer Firm, BiPar Sciences, Inc. for up to $500 Million
4/15/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) and Cardiome Pharma Corp. (COM.TO) Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of Atrial Fibrillation; Cardiome Could Receive up to $600 Million
4/9/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) to Buy Brazil's Medley for About $700 Million
4/6/2009
More...
|
Sanofi-Aventis (France) (SASY.PA) Acquires Laboratorios Kendrick in Mexico
4/2/2009
More...
|
Elan Corporation PLC (ELN) Shares Jump on Fresh Talk of Lundbeck Bid
3/26/2009
More...
|
Roche (RHHBY) (JOBS) Wins Genentech, Inc. (DNA) (JOBS) with Raised $46.8 Billion Offer
3/12/2009
More...
|
Gilead Sciences, Inc. (GILD) Buying CV Therapeutics, Inc. (CVTX) for $1.4 Billion
3/12/2009
More...
|
Evotec AG (EVTG.F) and Roche (RHHBY) to Develop EVT 101 for Treatment-Resistant Depression; Deal Valued at More Than $300 Million
3/9/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) to Buy Schering-Plough Corporation (SGP) (JOBS) for $41.1 Billion
3/9/2009
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) (JOBS) Buys 2 Hepatitis Drugs for $376.8 Million; Aquires ViroChem Pharma Inc.
3/4/2009
More...
|
CV Therapeutics, Inc. (CVTX) (JOBS) Rejects Astellas Pharma Inc.'s (JOBS) Bid
2/20/2009
More...
|
Novartis AG to Pay Portola Pharmaceuticals, Inc. $75 Million for Anti-clotting Drug; Portola to Receive $500 Million in Potential Milestone Payments Plus Royalties on Future Sales
2/12/2009
More...
|
Merck & Co., Inc. (MRK) (JOBS) to Pay $130 Million to Insmed Incorporated (INSM) in Biologics Deal
2/12/2009
More...
|
Lundbeck Inc. (formerly Ovation Pharmaceuticals) to Buy OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009) (JOBS) for up to $900 Million in Cash
2/9/2009
More...
|
GlaxoSmithKline (GSK) Pays Up to $450 Million for {2} (JOBS) AIDS Drug
2/6/2009
More...
|
Cephalon, Inc. (CEPH) Exercises Option to License Worldwide Rights to ImmuPharma plc (IMM.L) Product, Lupuzor
2/2/2009
More...
|
Genentech, Inc. (DNA) Calms Talk of New Roche (RHHBY) Offer
1/15/2009
More...
|
Cephalon, Inc. (CEPH) Signs Option Agreement to Acquire Ception Therapeutics; Cephalon Will Pay Ception $100 Million Upfront
1/14/2009
More...
|
Sequenom Inc. (SQNM) Makes Hostile Bid for EXACT Sciences Corporation (EXAS)
1/14/2009
More...
|
Elan Corporation PLC (ELN) CEO Says Not in Talks with Pfizer Inc. (PFE)
1/12/2009
More...
|
Wyeth Pharmaceuticals (Pennsylvania) (WYE) and Santaris Pharma A/S Announce Strategic Alliance to Develop RNA-based Medicines; Santaris May Receive Payments of up to $83 Million
1/12/2009
More...
|
Galapagos NV (GLPG.BR) Partners with Merck & Co., Inc. (MRK), GLPG Shares Jump; Total Payments Could Exceed $233 Million
1/9/2009
More...
|
Alnylam Pharmaceuticals (ALNY) and Cubist Pharmaceuticals, Inc. (CBST) Form Strategic Collaboration to Develop and Commercialize RNAi Therapeutics Targeting Respiratory Syncytial Virus (RSV) Infection; Alnylam to Get $20 Million Upfront
1/9/2009
More...
|
BioMarin Pharmaceutical Inc. (BMRN) and La Jolla Pharmaceutical Company (LJPC) Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent; BioMarin May Spend $289 Million for La Jolla's Drug
1/7/2009
More...
|
Endo Pharmaceuticals (ENDP) To Buy Indevus Pharmaceuticals, Inc. (IDEV) in $637 Million Deal
1/6/2009
More...
|
Bristol-Myers Squibb Company (BMY) (JOBS) to Pay $240 Million to Exelixis, Inc. (EXEL) to Co-Develop Two Cancer Drugs
12/12/2008
More...
|
Merck & Co., Inc. (MRK) (JOBS) Starts Generic Arm to Copy Biologic Medicines
12/9/2008
More...
|
Ascent Therapeutics and Novartis AG Option Fund Enter into Licensing Option Agreement for Select Pepducin(R) Drug Candidates; $200M Pact
12/8/2008
More...
|
Alkermes (ALKS)' Deal with Cephalon, Inc. (CEPH) Ends; Raises '09 View
12/2/2008
More...
|
Johnson & Johnson (JNJ) (JOBS) Announces Definitive Agreement to Acquire Mentor Corporation (MNTR) for Approximately $1.07 Billion in Cash
12/1/2008
More...
|
Eli Lilly and Company (LLY) (JOBS) Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics Corporation (UTHR); Lilly Takes $150 Million Equity Stake in United Therapeutics
11/17/2008
More...
|
Affymetrix (Santa Clara, California) (AFFX) to Acquire Panomics, Inc.
11/11/2008
More...
|
BTG plc (BGC.L) Signs Up To $320 Million Drug Deal With Onyx Pharmaceuticals, Inc. (ONXX) (JOBS)
11/7/2008
More...
|
Osiris Therapeutics, Inc. (OSIR) Leaps on $1.38 Billion Genzyme Corporation (GENZ) Stem-Cell Deal
11/4/2008
More...
|
Replidyne, Inc. (RDYN) to Be Bought by Private Medical Device Maker, Cardiovascular Systems, Inc.
11/4/2008
More...
|
Nektar Therapeutics (NKTR) (JOBS) Sells Pulmonary Business to Novartis AG (JOBS) for $115 Million; Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
10/21/2008
More...
|
Myriad Genetics, Inc. (MYGN) to Spin Off Drug Development Business from Its Molecular Diagnostics Business
10/21/2008
More...
|
King Pharmaceuticals®, Inc. Extends Tender Offer to Acquire Alpharma Inc. (ALO)
10/13/2008
More...
|
Pfizer Inc. (PFE) Creates 3 Units as Realignment Continues
10/7/2008
More...
|
Eli Lilly and Company (LLY) (JOBS) Agrees to Buy ImClone Systems Incorporated (IMCL) (JOBS) for $6.5 Billion
10/6/2008
More...
|
ImClone Systems Incorporated (IMCL) (JOBS) Rejects New, Higher Bid; Icahn Calls New Bristol-Myers Squibb Company (BMY) (JOBS) Bid for Imclone "Absurd"
9/24/2008
More...
|
BTG plc (BGC.L) to Buy Protherics PLC for Around 218.1 Million Pounds
9/18/2008
More...
|
Bayer HealthCare (BAY) (JOBS) Buys German Biotech Direvo Biotech AG for 210 Million Euros (Approx. $300 Million)
9/16/2008
More...
|
Biovitrum AB to Acquire Kepivance(R) and Stemgen(R) and Exclusively License Kineret(R) from Amgen (AMGN); Upfront Payment $130M
9/15/2008
More...
|
King Pharmaceuticals®, Inc. Ups Alpharma Inc. (ALO) Offer to $1.6 Billion, Goes Hostile
9/12/2008
More...
|
GlaxoSmithKline (GSK) (JOBS) Signs Up to $1.5 Billion Drug Deal with Cellzome AG
9/10/2008
More...
|
Pfizer Inc. (PFE) (JOBS) Gains Rights to Medivation, Inc. (MDVN) Alzheimer's Drug for $725 Million
9/3/2008
More...
|
Bristol-Myers Squibb Company (BMY) (JOBS) and PDL BioPharma, Inc. (PDLI) Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma; PDL BioPharma Receive Upfront Cash $30 Million
8/20/2008
More...
|
Cytos Biotechnology AG Shares Surge on $138 Million Pfizer Inc. (PFE) (JOBS) Vaccine Deal
8/15/2008
More...
|
Australia's CSL Limited (CMXHF.PK) to Buy Talecris Biotherapeutics for $3.1 Billion
8/13/2008
More...
|
Genentech, Inc. (DNA) Rejects Roche (RHHBY)'s $43.7 Billion Bid as Low
8/13/2008
More...
|
Celgene (CELG) Pulls Out of GPC Biotech AG (GPCG.DE) Prostate Cancer Drug Deal
8/7/2008
More...
|
ImClone Systems Incorporated (IMCL) Says Bristol-Myers Squibb Company (BMY) (JOBS) Bid is 'Substantially' Too Low
8/4/2008
More...
|
Roche (RHHBY) (JOBS) Offers to Buy Out Genentech, Inc. (DNA) (JOBS) for $43.7 Billion
7/21/2008
More...
|
Teva Pharmaceutical Industries Limited (TEVA) (JOBS) to Buy Barr Pharmaceuticals, Inc. (BRL) (JOBS) for $7.46 Billion, Boost Generic Lead
7/18/2008
More...
|
Genzyme Corporation (GENZ) (JOBS) and PTC Therapeutics, Inc. (JOBS) Announce Collaboration on Small Molecule for Genetic Diseases; Genzyme to Make Up-front Payment of $100 Million
7/17/2008
More...
|
ViroPharma Incorporated (VPHM) to Acquire Lev Pharmaceuticals, Inc. for $442.9 Million; Will Recieve Additional $174.6 Million in Bonus Payments if Lev's Cinryze Drug Meets Regulatory and Sales Goals
7/15/2008
More...
|
GlaxoSmithKline (GSK) (JOBS) to Pay Actelion Ltd. (ALIOF.PK) up to $3.3 Billion for Drug Rights
7/14/2008
More...
|
Eli Lilly and Company (LLY) Launched in Collaboration with Enlight Biosciences (JOBS), Merck & Co., Inc. (MRK) (JOBS), and Pfizer Inc. (PFE) (JOBS)
7/10/2008
More...
|
Germany's Fresenius AG to Buy APP Pharmaceuticals for $3.7 Billion
7/7/2008
More...
|
Boehringer Ingelheim Corporation to Buy U.S. Biotech Company Actimis Pharmaceuticals, Inc. for Up to $515M
6/17/2008
More...
|
Invitrogen Corporation (IVGN) to Buy Applied Biosystems (ABI) for $6.7 Billion
6/12/2008
More...
|
Ranbaxy Laboratories to Bring in Daiichi Sankyo Co Ltd. as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
6/11/2008
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
6/11/2008
More...
|
Johnson & Johnson (JNJ) Signs Potential $500 Million Drug Deal with Astex Therapeutics
6/9/2008
More...
|
Ipsen In 3 Deals Worth $450M; Company to Build A Fully-Fledged Commercial Presence In North America -- $404M Tercica, Inc. (TRCA) Merger Deal; Vernalis PLC (VNLS) To Sell Apokyn And U.S. Commercial Operations for $17.5M; Octagon Corp. to be Acquired
6/5/2008
More...
|
Icahn Reports Increased Stake in Amylin Pharmaceuticals, Inc. (AMLN)
5/22/2008
More...
|
Shareholder Demands Enzon Pharmaceuticals, Inc. (ENZN) Explore All Strategic Alternatives for Commercial Operations
5/20/2008
More...
|
Medivir AB (MVIRb.F) Broadens Its Hepatitis C Collaboration With Tibotec BVBA, Entering A Partnership In The Field Of HCV Polymerase
5/15/2008
More...
|
DuPont (DD) and Genencor International, Inc. Create World-Leading Cellulosic Ethanol Company
5/14/2008
More...
|
Bristol-Myers Squibb Company (BMY) and KAI Pharmaceuticals, Inc. Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease; KAI Will Receive An Upfront Cash Payment Of $25M
5/13/2008
More...
|
Astellas Pharma Inc., CoMentis, Inc. Sign $760M Alzheimer's Deal
4/25/2008
More...
|
GlaxoSmithKline (GSK) to Acquire Sirtris Pharmaceuticals (SIRT), a World Leader in "Sirtuin" Research and Development for $720M
4/23/2008
More...
|
GlaxoSmithKline (GSK) Boosts Biotech with $600M Regulus Therapeutics, LLC Deal
4/17/2008
More...
|
Roche (RHHBY) Acquires UK Biotech Plramed for $160M
4/15/2008
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) to Buy Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) for $8.8 Billion
4/10/2008
More...
|
Cell Genesys, Inc. (CEGE) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) in $320M Agreement; Global Alliance for the Development and Commercialization of GVAX Immunotherapy for Prostate Cancer
4/1/2008
More...
|
Eli Lilly and Company (LLY) and Transition Therapeutics Inc. (TTH.TO) Announce Licensing and Collaboration Agreement
3/14/2008
More...
|
Silence Therapeutics plc and AstraZeneca PLC (AZN) Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
3/13/2008
More...
|
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen Corporation (CYTO) for $22.6M
3/11/2008
More...
|
Alkermes (ALKS) Receives Notice from Eli Lilly and Company (LLY) Terminating Inhaled Insulin Program
3/7/2008
More...
|
Pfizer Inc. (PFE) to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform
3/3/2008
More...
|
AstraZeneca PLC (AZN) Spins Out Albireo
2/14/2008
More...
|
Sanofi-Aventis (France) (SASY.PA), Dyax Corp. (DYAX) Sign $500M Deal on DX-2240 Antibody
2/12/2008
More...
|
Amgen (AMGN) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) in Exclusive Tie-up for Japanese Market; Takeda to Buy Amgen Japan Unit, Japan Drug Rights For Up to $1.2B
2/4/2008
More...
|
GlaxoSmithKline (GSK) Signs Amira Pharmaceuticals, Inc. Drug Deal For Up To $425 Million
2/4/2008
More...
|
Sepracor, Inc. (SEPR) Acquires Exclusive U.S. Rights to Nycomed's ALVESCO(R) HFA and OMNARIS(TM) AQ Products as Well as Ciclesonide Pipeline; Nycomed will Receive an Upfront Payment of $150M
1/29/2008
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Shares Leap on Genzyme Corporation (GENZ) Cholesterol Deal
1/8/2008
More...
|
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer Inc. (PFE) To Develop and Commercialize RNAi Hepatitis C Drug
1/7/2008
More...
|
Osiris Therapeutics, Inc. (OSIR) Awarded Department of Defense Contract for Prochymal(TM) Fully Valued at $224.7 Million
1/4/2008
More...
|
Merck & Co., Inc. (MRK) and Addex Pharmaceuticals (ADXN.SW) in $700M Schizophrenia Deal
1/3/2008
More...
|
Sepracor, Inc. (SEPR) in License Pact to Develop Anti-Epileptic Compound; Deal Potentially Worth Up to $175M
1/2/2008
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) No Longer for Sale; Shares Plunge
12/13/2007
More...
|
GlaxoSmithKline (GSK) Boosts Pipeline with Two New Biotech Deals
12/13/2007
More...
|
Japan's Eisai Company, Ltd. (ESALY.PK) to Buy U.S. MGI PHARMA, INC. (MOGN) (Jobs) for $3.9 Billion
12/10/2007
More...
|
Genzyme Corporation (GENZ) CEO Says Biotech Firm is Not for Sale- Wall Street Journal
12/6/2007
More...
|
Pfizer Inc. (PFE) to Develop Pain Drugs with Adolor Corporation (ADLR); Adolor to Receive $30M Upfront and Future Payments Up to $232.5M
12/5/2007
More...
|
Novartis AG, MorphoSys AG in $600 Million Antibody Deal
12/3/2007
More...
|
Pfizer Inc. (PFE) to Acquire Coley Pharmaceutical Group for $164 Million
11/16/2007
More...
|
Icahn Strikes Again: Buys A Stake In Genzyme Corporation (GENZ)
11/15/2007
More...
|
Ventana Medical Systems, Inc. (VMSI) (Jobs) Enters into Confidentiality Agreement with Roche Holding AG (RHHBF.PK) (Jobs)
11/14/2007
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
11/14/2007
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Says Procter & Gamble (PG) Terminates Nasal Spray Collaboration
11/7/2007
More...
|
GTx, Inc. (GTXI) and Merck & Co., Inc. (MRK) in Drug Venture to Treat Age-Related Muscle Loss; GTx to Receive $40 Million Upfront
11/6/2007
More...
|
U.S. Approves Bristol-Myers Squibb (BMY)'s $430 Million Purchase of Adnexus Therapeutics
10/12/2007
More...
|
GlaxoSmithKline (GSK) Inks Up to $1 Billion Deal for Synta Pharmaceuticals Cancer Drug
10/10/2007
More...
|
Wyeth (WYE) (Jobs) Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
10/5/2007
More...
|
Amgen (AMGN) (Jobs) Ditches Plan for Irish Plant, Company Suspends 1100 Jobs; Loss Of $1B Amgen (AMGN) Plant Is Major Blow To Ireland
10/4/2007
More...
|
PerkinElmer, Inc. (PKI) (Jobs) to Expand Genetic Screening Business Through Acquisition of ViaCell, Inc. (VIAC); Approximately $300 Million
10/2/2007
More...
|